Psilocybin, the active ingredient in magic mushrooms, is getting attention in the world of mental health. A new study shows promising results for people struggling with alcohol use disorder (AUD). Dr. Dan Bober, MHTN Chief Medical Officer, joins hosts Jessica Reyes and Patricia Wu to break down the research and offer his expert perspective on psilocybin-assisted therapy. He discusses where this treatment stands, its potential role in addiction recovery, and what the future might hold.
Psilocybin and Addiction Treatment
Dr. Bober explains the connection between psilocybin, brain activity, and how it might help people with AUD. He emphasizes the importance of combining this approach with traditional therapy.
A Treatment in Development
Still in its early phases, psilocybin-assisted therapy shows signs of being a helpful tool in treating addiction, alongside other mental health conditions. Dr. Bober puts its development stage into perspective.
When Could This be Available?
While compassionate use and personal experimentation are happening, Dr. Bober highlights the need for larger-scale studies before this treatment becomes widely accessible.
